Sun Pharma plant feels the heat of FDA import ban

Save

A Sun Pharma plant has joined the growing ranks of Indian operations banned by the FDA for manufacturing issues. Unlike Ranbaxy Laboratories and Wockhardt, two other Indian generics players that have recently felt the sting of import alerts, the Sun Pharma plant is not key to its financial success.